Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Feb 28, 2025 | (FY)Feb 29, 2024 | (FY)Feb 28, 2023 | |
|---|---|---|---|
| Total revenue | 20.80%948.5M | 23.81%785.21M | 634.2M |
| Cost of revenue | -5.66%187.32M | -1.97%198.56M | 202.56M |
| Gross profit | 29.75%761.17M | 35.91%586.65M | 431.64M |
| Operating expense | 4.65%753.07M | 2.99%719.62M | 698.72M |
| Operating profit | 106.09%8.1M | 50.21%-132.97M | -267.08M |
| Net non-operating interest income (expenses) | 47.49%-2.08M | 16.22%-3.96M | -4.73M |
| Non-operating interest income | 4,766.67%146K | 0.00%3K | --3K |
| Non-operating interest expense | -23.15%2.23M | 4.43%2.9M | --2.78M |
| Total other finance cost | ---- | -45.45%1.07M | --1.96M |
| Net investment income | |||
| Gain(Loss) on financial instruments designated as cash flow hedges | |||
| Gain(Loss) on derecognition of available-for-sale financial assets | |||
| Income from associates and other participating interests | |||
| Special income (charges) | |||
| Other non-operating income (expenses) | -600.50%-3.97M | 535.20%794K | 125K |
| Income before tax | 101.50%2.05M | 49.89%-136.14M | -271.69M |
| Income tax | -1,796.42%-8.99M | 0.00%530K | 530K |
| Net income | 108.08%11.04M | 49.79%-136.67M | -272.22M |
| Net income continuous operations | 108.08%11.04M | 49.79%-136.67M | ---272.22M |
| Noncontrolling interests | |||
| Net income attributable to the company | 108.08%11.04M | 49.79%-136.67M | -272.22M |
| Preferred stock dividends | |||
| Other under preferred stock dividend | 0 | 0 | 0 |
| Net income attributable to common stockholders | 108.08%11.04M | 49.79%-136.67M | -272.22M |
| Gross dividend payment | |||
| Basic earnings per share | 107.95%3.6 | 49.39%-45.2604 | -89.4351 |
| Diluted earnings per share | 106.96%3.15 | 49.39%-45.2604 | -89.4351 |
| Dividend per share | |||
| Currency Unit | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |